Session

Ureteroscopy: New technology and stents

Poster Session 81

  • Location:
    Room Paris (Hall B2, level 0)
  • Chairs:
     M. Brehmer, Aarhus N (DK)
     L. Cindolo, Vasto (IT)
     P.J.S. Osther, Fredericia (DK)
  • Aims and objectives of this session

    Ureteroscopy became the treatment of choice for most stones. Technology still advances rapidly and this session will give an update on latest developments in URS and stenting

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
1029
Durability of flexible ureteroscopy and predictors of repair: A prospective multi-center study

By: Chi T.1, Usawachintachit M.1, Chu C.1, Allen I.1, Xu A.1, Duty B.2, Sur R.3, Zaid U.1, Ramaswamy K.1, Sorensen M.4, Harper J.4, Stoller M.1

Institutes: 1University of California, San Francisco, Dept. of Urology, San Francisco, United States of America, 2Oregon Health & Science University, Dept. of Urology, Portland, United States of America, 3University of California, San Diego, Dept. of Urology, La Jolla, United States of America, 4University of Washington, Dept. of Urology, Seattle, United States of America

1030
Flexible ureteroscopy durability in the hands of UK surgeons: A snapshot

By: Finch W.1, Rukin N.2, Kumar P.3, Wiseman O.4

Institutes: 1Norfolk and Norwich University Hospital, Dept. of Urology, Norwich, United Kingdom, 2New Cross Hospital, Dept. of Urology, Wolverhampton, United Kingdom, 3Royal Berkshire Hospital, Dept. of Urology, Reading, United Kingdom, 4Addenbrookes Hospital, Dept. of Urology, Cambridge, United Kingdom

1031
Evaluation of a novel single use flexible ureteroscope

By: Kaplan A.G.1, Neisius A.3, Radvak D.2, Shin R.1, Ackerman A.J.1, Chen T.T.1, Dale J.1, Scales, Jr. C.D.1, Ferrandino M.N.1, Simmons W.N.2, Preminger G.M.1, Lipkin M.E.1

Institutes: 1Duke University Medical Center, Dept. of Urologic Surgery, Durham, United States of America, 2Duke University, Dept. of Mechanical Engineering and Materials Science, Durham, United States of America, 3Universitätsmedizin der Johannes Gutenberg-Universität, Dept. of Urology, Mainz, Germany

1032
Prospective European multicentre clinical results of kidney stone treatment using the Avicenna Roboflex URS robot

By: Klein J-T.1, Fiedler M.2, Kabuki A.S.4, Saglam R.3, Rassweiler J.2

Institutes: 1Universitätsklinikum Ulm, Dept. of Urology & Pediatric Urology, Ulm, Germany, 2SLK-Klinikum Am Gesundbrunnen, Dept. of Urology & Pediatric Urology, Heilbronn, Germany, 3Saglams Hospital, Dept. of Urology & Pediatric Urology, Ankara, Turkey, 4Medicana International Hospital, Dept. of Urology, Ankara, Turkey

1033
RIRS: Dusting vs fragmentation for renal stone < 2 cm

By: Gamal Saad W., Mmdouh A.

Institutes: Sohag University Hospital, Dept. of Urology, Sohag, Egypt

1034
Stone/tissue differentiation with a pilot-laser of a holmium YAG-laser-lithotripsy device

By: Lange B.2, Jocham D.1, Brinkmann R.2, Cordes J.1

Institutes: 1Universität Zu Lübeck, Dept. of Urology, Lübeck, Germany, 2Medical Laser Center Lübeck Gmbh, Lübeck, Germany

1035
Ultra-short, short, medium and long-pulse laser lithotripsy performance

By: Kronenberg P.1, Traxer O.2

Institutes: 1Hospital Prof. Doutor Fernando Fonseca, Dept. of Urology, Amadora, Portugal, 2Université Paris 6 Pierre Et Marie Curie – Hôpital Tenon, Dept. of Urology, Paris, France

1036
Laser fibers passage in extreme circumstances: Comparison of laser fibers passage in ureteroscopic maximum deflection and their influence on bending and irrigation

By: Baghdadi M., Emiliani E., Talso M., Servian P., Barreiro A., Orosa A., Proietti S., Traxer O.

Institutes: Tenon Hospital, Université Pierre Et Marie Curie – Paris Vi, Dept. of Urology, Paris, France

1037
Old versus new laser lithotripter model – a comparison within the same brand

By: Kronenberg P.1, Traxer O.2

Institutes: 1Hospital Prof. Doutor Fernando Fonseca, Dept. of Urology, Amadora, Portugal, 2Université Paris 6 Pierre Et Marie Curie – Hôpital Tenon, Dept. of Urology, Paris, France

1038
A randomized controlled trial comparing antimicrobial coated (silver sulfadiazine) ureteral stents with non-coated stents

By: Lachine M., El-Nahas A., Elsawy E., Mosbah A., El-Kappany H.

Institutes: Urology and Nephrology Centre, Mansoura University, Dept. of Urology, Mansoura, Egypt

1039
Does increased ureteric stent encrustation cause greater patient morbidity and stent related symptoms?

By: Raja A.1, Sherif M.2, Hobot J.2, Joshi H.1

Institutes: 1University Hospital of Wales, Dept. of Urology, Cardiff, United Kingdom, 2Cardiff University, Dept. of Medicine, Cardiff, United Kingdom

1040
Impact of preoperative D-J stenting on success and complications of RIRS

By: Şahin T.1, Senocak C.1, Ozcan C.1, Oguz U.2, Ozyuvali E.3, Yordam M.1, Damar E.1, Bozkurt O.F.1

Institutes: 1Kecioren Training and Research Hospital, Dept. of Urology, Ankara, Turkey, 2Giresun University,Faculty of Medicine, Dept. of Urology, Giresun, Turkey, 3Turgut Ozal University, Faculty of Medicine, Dept. of Urology, Ankara, Turkey

1041
Economic aspects of morbidity caused by ureteral stents

By: Abt D.1, Staubli S.E.1, Mordasini L.1, Engeler D.S.1, Sauter R.2, Schmid H-P.1

Institutes: 1Cantonal Hospital St. Gallen, Dept. of Urology, St. Gallen, Switzerland, 2Cantonal Hospital St. Gallen, Dept. of Clinical Trials , St. Gallen, Switzerland

Summary and context
 M. Brehmer, Aarhus N (DK)